NEWS

Stay Up To Date

Featured image for “Gilead Must Commit to Immediately and Broadly License Lenacapavir to the MPP and ViiV Must Take Steps to Expand and Unshroud its MPP License on Dolutegravir”
August 16, 2024

Gilead Must Commit to Immediately and Broadly License Lenacapavir to the MPP and ViiV Must Take Steps to Expand and Unshroud its MPP License on Dolutegravir

Featured image for “Gilead’s ESG Awards Are Worthless. What About Drug Prices?”
February 29, 2024

Gilead’s ESG Awards Are Worthless. What About Drug Prices?

Featured image for “Federal court rejects drugmaker’s efforts to end lawsuit claiming they delayed more effective HIV treatment for more expensive, less effective drug”
January 16, 2024

Federal court rejects drugmaker’s efforts to end lawsuit claiming they delayed more effective HIV treatment for more expensive, less effective drug

Featured image for “‘Responsible Investors: Dump Gilead’ Says AHF Ad”
October 9, 2023

‘Responsible Investors: Dump Gilead’ Says AHF Ad

Featured image for “HIV drugmaker will pay $246 million to settle suit over generic meds delay”
October 4, 2023

HIV drugmaker will pay $246 million to settle suit over generic meds delay

Featured image for “How a Drugmaker Profited by Slow-Walking a Promising H.I.V. Therapy”
October 4, 2023

How a Drugmaker Profited by Slow-Walking a Promising H.I.V. Therapy

Featured image for “Gilead must stand trial over defective HIV drug claims”
October 4, 2023

Gilead must stand trial over defective HIV drug claims

Featured image for “AHF Protest: Gilead Destroys Rx Safety Net for its Own Profit”
December 12, 2022

AHF Protest: Gilead Destroys Rx Safety Net for its Own Profit

Featured image for “AHF Protests Gilead over Drug Pricing @ Morgan Stanley Conf. in NYC”
December 12, 2022

AHF Protests Gilead over Drug Pricing @ Morgan Stanley Conf. in NYC

Featured image for “AHF Advocates to Hammer Gilead with Weeklong Protests”
December 12, 2022

AHF Advocates to Hammer Gilead with Weeklong Protests